Z

Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456

Watchlist Manager
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Watchlist
Price: 15.57 CNY -0.19% Market Closed
Market Cap: 14B CNY
Have any thoughts about
Zhejiang Jiuzhou Pharmaceutical Co Ltd?
Write Note

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Total Liabilities & Equity
ÂĄ11.1B
CAGR 3-Years
22%
CAGR 5-Years
28%
CAGR 10-Years
20%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Liabilities & Equity
ÂĄ33B
CAGR 3-Years
17%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Total Liabilities & Equity
ÂĄ17B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
18%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Liabilities & Equity
ÂĄ48.2B
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
19%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Liabilities & Equity
ÂĄ54.4B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
15%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Liabilities & Equity
ÂĄ1.4B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
11.1B CNY

Based on the financial report for Jun 30, 2024, Zhejiang Jiuzhou Pharmaceutical Co Ltd's Total Liabilities & Equity amounts to 11.1B CNY.

What is Zhejiang Jiuzhou Pharmaceutical Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
20%

Over the last year, the Total Liabilities & Equity growth was -2%. The average annual Total Liabilities & Equity growth rates for Zhejiang Jiuzhou Pharmaceutical Co Ltd have been 22% over the past three years , 28% over the past five years , and 20% over the past ten years .

Back to Top